Zurich Cantonal Bank’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $291K | Buy |
35,771
+23
| +0.1% | +$187 | ﹤0.01% | 1974 |
|
|
2025
Q1 | $281K | Buy |
35,748
+2,524
| +8% | +$19.8K | ﹤0.01% | 1922 |
|
|
2024
Q4 | $495K | Buy |
33,224
+2,443
| +8% | +$36.4K | ﹤0.01% | 1634 |
|
|
2024
Q3 | $471K | Buy |
30,781
+843
| +3% | +$12.9K | ﹤0.01% | 1605 |
|
|
2024
Q2 | $456K | Sell |
29,938
-307
| -1% | -$4.68K | ﹤0.01% | 1549 |
|
|
2024
Q1 | $571K | Buy |
30,245
+11,362
| +60% | +$215K | ﹤0.01% | 1379 |
|
|
2023
Q4 | $361K | Buy |
18,883
+5,151
| +38% | +$98.4K | ﹤0.01% | 1719 |
|
|
2023
Q3 | $246K | Buy |
13,732
+2,289
| +20% | +$41.1K | ﹤0.01% | 1839 |
|
|
2023
Q2 | $232K | Buy |
11,443
+160
| +1% | +$3.25K | ﹤0.01% | 1828 |
|
|
2023
Q1 | $206K | Sell |
11,283
-111
| -1% | -$2.03K | ﹤0.01% | 1839 |
|
|
2022
Q4 | $236K | Sell |
11,394
-50
| -0.4% | -$1.03K | ﹤0.01% | 1731 |
|
|
2022
Q3 | $299K | Sell |
11,444
-415
| -3% | -$10.8K | ﹤0.01% | 1515 |
|
|
2022
Q2 | $301K | Sell |
11,859
-451
| -4% | -$11.4K | ﹤0.01% | 1556 |
|
|
2022
Q1 | $389K | Sell |
12,310
-238
| -2% | -$7.52K | ﹤0.01% | 1482 |
|
|
2021
Q4 | $508K | Buy |
12,548
+44
| +0.4% | +$1.78K | ﹤0.01% | 1432 |
|
|
2021
Q3 | $436K | Sell |
12,504
-180
| -1% | -$6.28K | ﹤0.01% | 1394 |
|
|
2021
Q2 | $348K | Buy |
12,684
+388
| +3% | +$10.6K | ﹤0.01% | 1450 |
|
|
2021
Q1 | $345K | Buy |
12,296
+4,499
| +58% | +$126K | ﹤0.01% | 1453 |
|
|
2020
Q4 | $202K | Buy |
7,797
+4,639
| +147% | +$120K | ﹤0.01% | 1839 |
|
|
2020
Q3 | $54K | Buy |
3,158
+1,714
| +119% | +$29.3K | ﹤0.01% | 2236 |
|
|
2020
Q2 | $36K | Buy |
+1,444
| New | +$36K | ﹤0.01% | 2304 |
|